Chicago Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-8,000
Closed -$470K 42
2023
Q4
$470K Buy
+8,000
New +$470K 0.75% 28